Avinger this week announced that it received FDA 510(k) clearance for a new clinical indication for its Pantheris image-guided atherectomy system. The new indication allows the Redwood City, California-based company to market the device for in-stent restenosis (ISR) treatment in the lower extremity arteries. Get the full story on our sister site, Medical Tubing + Extrusion.
Avinger
Avinger reports Street-beating revenues in Q2
Avinger (NSDQ:AVGR) shares stood still this morning on second-quarter sales numbers that topped the consensus forecast. The Redwood City, Calif.-based image-guided catheter developer posted losses of -$3.5 million on sales of $2.8 million for the three months ended June 30, 2021, for a 43.1% bottom-line gain on sales growth of 9.5%. Earnings per share came […]
Avinger slides on mixed bag Q4 results
Avinger (NSDQ:AVGR) posted fourth-quarter results today that missed the earnings consensus on Wall Street but matched on sales. The Redwood City, Calif.-based company — maker of an image-guided, catheter-based peripheral artery disease treatment — reported losses of –$4.6 million, or –7¢ per share, on sales of $2.73 million for the three months ended Dec. 31, 2020, […]
Avinger looks to raise $3.15m
Avinger (NSDQ:AVGR) announced that it priced an underwritten public offering with expected gross proceeds of approximately $3.15 million. The offering includes 12.6 million shares of its treat peripheral artery disease treatment device developer Avinger’s common stock at 25¢ per share with Aegis Capital acting as the sole bookrunner. Redwood City, Calif.-based Avinger earmarked the potential proceeds […]
Avinger closes $5m offering
Avinger (NSDQ:AVGR) said yesterday that it closed a stock offering worth nearly $4.5 million for its line of devices designed to treat peripheral artery disease. The commercial-stage medical device company designs image-guided, catheter-based systems to diagnose and treat PAD. The closing of the equity offering came five days after the company priced the offering, as […]
Avinger prices $5m offering
Avinger (NSDQ:AVGR) yesterday priced a stock offering worth nearly $5 million for its line of devices to treat peripheral artery disease. The $4.5 million offering, of more than 3.8 million shares at $1.18 apiece, also includes a 45-day underwriters option on another 572,000 shares that would add $675,000 if exercised in full. The float is slated […]
Avinger pulls the trigger on 1-10 reverse split
Avinger (NSDQ:AVGR) last week pulled the trigger on a one-for-10 reverse stock split to boost its share price above the Nasdaq exchange’s $1-per-share minimum. The split took the number of outstanding shares from roughly 64.2 million to about 6.4 million, Redwood City, Calif.-based Avinger said. AVGR shares, which closed at 41.8¢ apiece June 21, jumped to […]
UPDATE: Avinger shares tumble on Q1 earnings miss
Updated to include market reaction. Shares in Avinger (NSDQ:AVGR) are falling today after the medical device maker posted first quarter earnings that missed Wall Street’s expectations for both losses per share and sales. The Redwood City, Calif.-based company posted losses of approximately $6 million, or 14¢ per share, on sales of $1.8 million for the three […]
Avinger wins FDA nod for Pantheris SV small vessel atherectomy device
Avinger (NSDQ:AVGR) said today that it won FDA 510(k) clearance for its Pantheris SV small vessel image-guided atherectomy system. The Pantheris SV is an extension of the Redwood City, Calif.-based company’s lumivascular image-guided atherectomy platform which it hopes will expand the available market for its Pantheris devices by up to 50%. The newly cleared device features a […]
Avinger shares rise despite Q4 earnings miss
Shares in Avinger (NSDQ:AVGR) have risen today despite the medical device maker posting fourth quarter earnings that missed expectations on Wall Street. The Redwood City, Calif.-based company posted losses of $6.9 million, or 31¢ per share, on sales of $2 million for the three months ended December 31, seeing losses shrink 31.8% while sales grew 6% […]
Avinger touts preliminary Pantheris OCT vascular imaging analysis data
Avinger (NSDQ:AVGR) this week released preliminary analysis results from its SCAN post-market study comparing optical coherence (OCT) to intravascular ultrasound (IVUS), touting that data indicated that OCT imaging with its Pantheris system showed statistical superiority or equivalence to IVUS. In the study, researchers compared 240 matched images, 120 OCT and 120 IVUS, captured at identical positions […]
